Patent · US Active

Assays for agents affecting megakaryocyte development

US9017936B2 · kind B2 · utility

0Cited by

0References

40Claims

0Family size

Assignees

SHIRE HUMAN GENETIC THERAPIES, INC. · US
University of Wales Institute, Cardiff · GB

Inventors

Jorge Daniel Erusalimsky · London, GB
Maninder Ahluwalia · Cardiff, GB

Key dates

Filing date	Oct 5, 2010
Grant date	Apr 28, 2015
Priority date	—
Expiry date	Mar 1, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Methods and kits for identifying candidate anti-megakaryocyte agents are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.